T790M mutation sensitizes non-small cell lung cancer cells to radiation via suppressing SPOCK1
{{output}}
Background: Approximately 50% of patients harbor the T790M mutation after developing first-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance. Evidence has showed the major treatment failu... ...
